Abstract
Two recent reports provide compelling insights into the role for RANK and its ligand, RANKL, in progestin-dependent mammary tumorigenesis. These findings build upon a considerable body of evidence pointing to the RANK signaling pathway as being a key mediator of progestin action in the mammary glands.
Original language | English (US) |
---|---|
Article number | 301 |
Journal | Breast Cancer Research |
Volume | 13 |
Issue number | 1 |
DOIs | |
State | Published - Jan 28 2011 |
ASJC Scopus subject areas
- Cancer Research
- Oncology
- Medicine(all)